GDOC Among Gold ETFs
End-of-day Nov 16, 2026 · 40 Gold ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.2% | −1.4% | +5.4% | +3.4% | +9.5% | +8.5% | +37.9% | — | +0.4% |
| Peer average | −1.7% | −4.2% | −4.9% | −8.2% | +0.1% | +2.2% | +88.7% | +74.9% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
No price history yet: […]
$144 of every $1,000 in GDOC is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 14.44% | $1,443.63 | 2,066 | $3.0M |
| 2 | JNJJohnson & Johnson | Healthcare | 6.29% | $629.10 | 4,548 | $1.3M |
| 3 | UNHUnitedhealth Group Incorporated | Healthcare | 5.74% | $574.36 | 2,912 | $1.2M |
| 4 | MRKMerck | Healthcare | 4.87% | $487.17 | 6,811 | $1.0M |
| 5 | EWEdwards Lifesciences | Healthcare | 4.79% | $479.47 | 9,244 | $990K |
| 6 | VRTXVertex Pharmaceuticals Incorporated | Healthcare | 3.94% | $393.95 | 1,511 | $814K |
| 7 | AAgilent Technologies | Healthcare | 3.78% | $377.68 | 4,485 | $780K |
| 8 | TMOThermo Fisher Scientific | Healthcare | 3.78% | $377.60 | 1,114 | $780K |
| 9 | AZN.LAstrazeneca ORD | Healthcare | 3.38% | $338.06 | 3,778 | $698K |
| 10 | DXCMDexcom | Healthcare | 3.35% | $335.49 | 8,317 | $693K |
| 11 | GHGuardant Health | Healthcare | 3.24% | $323.92 | 4,411 | $669K |
| 12 | GILDGilead Sciences | Healthcare | 3.06% | $305.60 | 3,756 | $631K |
| 13 | ABBVAbbvie | Healthcare | 3.00% | $300.06 | 2,101 | $620K |
| 14 | LONN.SWLonza Group AG | Healthcare | 2.97% | $296.56 | 771 | $613K |
| 15 | CORCencora | Healthcare | 2.81% | $281.38 | 1,619 | $581K |
of the $263B in 46 Gold ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 14.44% |
| 2 | JNJ | Johnson & Johnson | 6.29% |
| 3 | UNH | Unitedhealth Group Incorporated | 5.74% |
| 4 | MRK | Merck & | 4.87% |
| 5 | EW | Edwards Lifesciences | 4.79% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 3.94% |
| 7 | A | Agilent Technologies | 3.78% |
| 8 | TMO | Thermo Fisher Scientific | 3.78% |
| 9 | AZN.L | Astrazeneca ORD | 3.38% |
| 10 | DXCM | Dexcom | 3.35% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 23, 2025 | Dec 30, 2025 | $0.11 |
| Dec 23, 2024 | Dec 30, 2024 | $0.0058 |
| Dec 26, 2023 | Jan 2, 2024 | $0.18 |
| Sep 26, 2022 | Sep 30, 2022 | $0.0000 |